Opportunity Information: Apply for CDC RFA EH15 150402CONT16
Apply for CDC RFA EH15 150402CONT16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "Newborn Screening for Severe Combined Immunodeficiency (SCID)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.065.
- This funding opportunity was created on Feb 19, 2016 and posted on Feb 19, 2016.
- Applicants must submit their applications by Apr 15, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Newborn Screening for Severe Combined Immunodeficiency (SCID)," is a continuation funding announcement from the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC). It is offered as a cooperative agreement, which generally means the CDC expects to have substantial involvement in the work funded, such as providing technical input, coordination support, or collaboration on program activities, rather than functioning purely as a pass-through funder. The activity category is listed as Health, and it is associated with CFDA number 93.065, which is commonly tied to CDC public health programs and cooperative agreements.
The opportunity is identified by the funding opportunity number "CDC RFA EH15 150402CONT16" and is specifically framed around newborn screening for SCID, a rare but life-threatening immune disorder where infants are born with severely impaired immune function. In practical terms, SCID screening programs are designed to detect affected newborns early, often before symptoms appear, so that timely clinical interventions (such as protective measures against infection and definitive treatments like hematopoietic stem cell transplantation, and in some cases gene therapy) can be pursued. Early identification through screening is widely recognized as critical because untreated SCID can lead to severe infections and high mortality in infancy, while early treatment can dramatically improve survival and long-term outcomes.
Because the announcement is categorized as a continuation, it is typically intended for recipients who already have an existing award or are partway through an ongoing project period and are seeking continued support to sustain or expand previously funded SCID newborn screening work. The eligibility field is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)," which indicates that eligibility is not limited to a single standard applicant type in the headline fields and would normally require consulting the full announcement to confirm exactly which organizations can apply (for example, certain public health entities, laboratories, or other designated partners). No award ceiling is specified in the summary data provided ("AwardCeiling: 0"), which usually indicates that the ceiling was not entered into this data extract or is defined elsewhere in the full funding announcement, and the number of expected awards is not shown in the provided record.
Key administrative dates included in the record show that the opportunity was created and posted on February 19, 2016, and that both the original and current closing dates were April 15, 2016. In short, this is a CDC cooperative agreement continuation opportunity focused on supporting ongoing public health efforts related to newborn screening for SCID, with the goal of strengthening early detection and follow-up systems that can connect identified infants to appropriate confirmatory testing and care as quickly as possible.
FAQs: Newborn Screening for Severe Combined Immunodeficiency (SCID)
What is the title of this grant opportunity?
The opportunity is titled "Newborn Screening for Severe Combined Immunodeficiency (SCID)".
Which federal agency is offering this funding?
This is offered by the U.S. Department of Health and Human Services (HHS), specifically the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism is this?
It is a cooperative agreement. This generally means the CDC expects to have substantial involvement in the funded work (for example, technical input, coordination support, or collaboration on program activities), rather than acting only as a pass-through funder.
Is this a new grant or a continuation?
This is a continuation funding announcement. Based on the information provided, it is typically intended for recipients who already have an existing award or are partway through an ongoing project period and are seeking continued support to sustain or expand previously funded SCID newborn screening work.
What is the focus area or activity category?
The activity category is listed as Health.
What is the CFDA number associated with this opportunity?
The record lists CFDA 93.065, which is commonly tied to CDC public health programs and cooperative agreements.
What is the funding opportunity number?
The funding opportunity number is CDC RFA EH15 150402CONT16.
What does SCID stand for, and why is it important in newborn screening?
SCID stands for Severe Combined Immunodeficiency, described here as a rare but life-threatening immune disorder in which infants are born with severely impaired immune function. Newborn screening is important because it aims to detect affected infants early, often before symptoms appear.
What is the goal of newborn screening programs for SCID?
SCID screening programs are designed to identify affected newborns as early as possible so they can be connected quickly to confirmatory testing and appropriate care.
Why is early identification of SCID emphasized in this opportunity?
Early identification is emphasized because untreated SCID can lead to severe infections and high mortality in infancy, while early treatment can dramatically improve survival and long-term outcomes.
What kinds of clinical interventions are mentioned once SCID is detected?
The description notes that early detection can enable timely clinical interventions such as protective measures against infection and definitive treatments like hematopoietic stem cell transplantation, and in some cases gene therapy.
What role does follow-up play in this opportunity?
The opportunity is framed around strengthening early detection and follow-up systems that can connect infants identified through screening to confirmatory testing and care as quickly as possible.
Who is eligible to apply based on the information provided?
The eligibility field is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)". That indicates eligibility is not limited to a single standard applicant type in the summary and would normally require the full announcement text to confirm which organizations can apply.
Does the summary specify an award ceiling (maximum award amount)?
No. The summary data shows "AwardCeiling: 0", which usually indicates the ceiling was not entered into this data extract or is defined elsewhere in the full funding announcement.
How many awards are expected?
The number of expected awards is not shown in the provided record.
When was this opportunity posted?
The record indicates the opportunity was created and posted on February 19, 2016.
What is the application closing date?
Both the original and current closing dates are listed as April 15, 2016.
What does it mean that this is a CDC cooperative agreement for SCID screening work?
Based on the description provided, it means the CDC is expected to be actively involved in the funded work (for example, through technical input or coordination support) while the recipient carries out program activities related to newborn screening for SCID and associated follow-up and care connections.
Browse more opportunities from the same category: Health
Next opportunity: Signal Processing at RF (SPAR)
Previous opportunity: FY 2016 Joint Technology Transfer Initiative
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA EH15 150402CONT16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA EH15 150402CONT16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Protecting and Improving Public Health Systems Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security Apply for CDC RFA GH14 141803CONT16 Funding Number: CDC RFA GH14 141803CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Prescription Drug Overdose Prevention for States Apply for CDC RFA CE15 150102CONT16 Funding Number: CDC RFA CE15 150102CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Bridges to the Doctorate (R25) Apply for PAR 16 109 Funding Number: PAR 16 109 Agency: HHS-NIH11 Category: Health Funding Amount: $300,000 |
| Bridges to the Baccalaureate (R25) Apply for PAR 16 110 Funding Number: PAR 16 110 Agency: HHS-NIH11 Category: Health Funding Amount: $300,000 |
| Biomarkers for the Lewy Body Dementias (U01) Apply for RFA NS 16 022 Funding Number: RFA NS 16 022 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Sustained Strengthening of Public Health Laboratory, Transfusion Services, and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia Apply for CDC RFA GH15 163002CONT16 Funding Number: CDC RFA GH15 163002CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| To Strengthen Collaboration between CDC and the National TB Controllers and the National Nurse Coalition Project Apply for CDC RFA PS12 120505CONT16 Funding Number: CDC RFA PS12 120505CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Global Partnerships for Cancer Prevention and Control Apply for CDC RFA DP13 131204CONT16 Funding Number: CDC RFA DP13 131204CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| State-based Public Health Laboratory Biomonitoring Programs Apply for CDC RFA EH14 140203CONT16 Funding Number: CDC RFA EH14 140203CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| International TNM and Capacity Building Apply for CDC RFA DP13 130904CONT16 Funding Number: CDC RFA DP13 130904CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Health Department Demonstration Projects for Comprehensive Prevention, Care, Behavioral Health, and Social Services for Men Who Have Sex with Men of Color Apply for CDC RFA PS15 150902CONT16 Funding Number: CDC RFA PS15 150902CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Standardizing Electronic Laboratory and Biomarker Reporting Apply for CDC RFA DP13 131104CONT16 Funding Number: CDC RFA DP13 131104CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| The Prevention and Control of Unintentional Injury and Violence Prevention Through the World Health Organization Apply for CDC RFA CE16 1601 Funding Number: CDC RFA CE16 1601 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| PPHF16: Heart Disease & Stroke Prevention Program and Diabetes Prevention – State and Local Public Health Actions to Prevent Obesity, Diabetes, and Heart Disease and Stroke – Financed Solely by 2016 Prevention and Public Health Funds Apply for CDC RFA DP14 142203PPHF16 Funding Number: CDC RFA DP14 142203PPHF16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Modeling of Infectious Disease Agent Study Research Projects (R01) Apply for PA 16 107 Funding Number: PA 16 107 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Evidence-Based Falls Prevention Programs in Tribal Communities Financed Solely by 2016 Prevention and Public Health Funds (PPHF-2016) Apply for HHS 2016 ACL AOA FP 0133 Funding Number: HHS 2016 ACL AOA FP 0133 Agency: HHS-ACL Category: Health Funding Amount: $150,000 |
| Enhancing Cancer Registries for Early Case Capture of Pediatric and Young Adult Cancer Cases Apply for CDC RFA DP14 140203CONT16 Funding Number: CDC RFA DP14 140203CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Developmental Behavioral Pediatrics Research Network Apply for HRSA 16 039 Funding Number: HRSA 16 039 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Biomarkers Discovery In Parkinsonism (U01) Apply for PAR 16 112 Funding Number: PAR 16 112 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| National Organizations’ Support for State Oral Health Programs Apply for CDC RFA DP13 131304CONT16 Funding Number: CDC RFA DP13 131304CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA EH15 150402CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.